Serveur d'exploration sur le patient édenté

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Anti-annexin V antibodies in patients with cerebrovascular disease

Identifieur interne : 008064 ( Main/Exploration ); précédent : 008063; suivant : 008065

Anti-annexin V antibodies in patients with cerebrovascular disease

Auteurs : N. Gašperši [Slovénie] ; U. Rot [Slovénie] ; S. U Nik [Slovénie] ; T. Kveder [Slovénie] ; B. Boži [Slovénie] ; B. Rozman [Slovénie]

Source :

RBID : ISTEX:E0B51C21E16FC9007046B8B0F3E4A2CA9904BE1A

Descripteurs français

English descriptors


Url:
DOI: 10.1136/ard.62.2.188


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Anti-annexin V antibodies in patients with cerebrovascular disease</title>
<author>
<name sortKey="Gaspersi, N" sort="Gaspersi, N" uniqKey="Gaspersi N" first="N" last="Gašperši">N. Gašperši</name>
</author>
<author>
<name sortKey="Rot, U" sort="Rot, U" uniqKey="Rot U" first="U" last="Rot">U. Rot</name>
</author>
<author>
<name sortKey=" U Nik, S" sort=" U Nik, S" uniqKey=" U Nik S" first="S" last=" U Nik">S. U Nik</name>
</author>
<author>
<name sortKey="Kveder, T" sort="Kveder, T" uniqKey="Kveder T" first="T" last="Kveder">T. Kveder</name>
</author>
<author>
<name sortKey="Bozi, B" sort="Bozi, B" uniqKey="Bozi B" first="B" last="Boži">B. Boži</name>
</author>
<author>
<name sortKey="Rozman, B" sort="Rozman, B" uniqKey="Rozman B" first="B" last="Rozman">B. Rozman</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E0B51C21E16FC9007046B8B0F3E4A2CA9904BE1A</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1136/ard.62.2.188</idno>
<idno type="url">https://api.istex.fr/document/E0B51C21E16FC9007046B8B0F3E4A2CA9904BE1A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">006F60</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006F60</idno>
<idno type="wicri:Area/Istex/Curation">006F60</idno>
<idno type="wicri:Area/Istex/Checkpoint">003690</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">003690</idno>
<idno type="wicri:doubleKey">0003-4967:2003:Gaspersi N:anti:annexin:v</idno>
<idno type="wicri:Area/Main/Merge">008299</idno>
<idno type="wicri:Area/Main/Curation">008064</idno>
<idno type="wicri:Area/Main/Exploration">008064</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Anti-annexin V antibodies in patients with cerebrovascular disease</title>
<author>
<name sortKey="Gaspersi, N" sort="Gaspersi, N" uniqKey="Gaspersi N" first="N" last="Gašperši">N. Gašperši</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Rheumatology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rot, U" sort="Rot, U" uniqKey="Rot U" first="U" last="Rot">U. Rot</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Neurology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey=" U Nik, S" sort=" U Nik, S" uniqKey=" U Nik S" first="S" last=" U Nik">S. U Nik</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Rheumatology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kveder, T" sort="Kveder, T" uniqKey="Kveder T" first="T" last="Kveder">T. Kveder</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Rheumatology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bozi, B" sort="Bozi, B" uniqKey="Bozi B" first="B" last="Boži">B. Boži</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Rheumatology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rozman, B" sort="Rozman, B" uniqKey="Rozman B" first="B" last="Rozman">B. Rozman</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Rheumatology, University Medical Centre, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Annals of the Rheumatic Diseases</title>
<title level="j" type="abbrev">Ann Rheum Dis</title>
<idno type="ISSN">0003-4967</idno>
<idno type="eISSN">1468-2060</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher>
<date type="published" when="2003-02">2003-02</date>
<biblScope unit="volume">62</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="188">188</biblScope>
</imprint>
<idno type="ISSN">0003-4967</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0003-4967</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aanxv</term>
<term>Abnormality</term>
<term>Aicher</term>
<term>American college</term>
<term>Ankylosing</term>
<term>Ankylosing spondylitis</term>
<term>Antinuclear antibodies</term>
<term>Antiphospholipid antibodies</term>
<term>Antiphospholipid syndrome</term>
<term>Apnoea syndrome</term>
<term>Arteritis</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Basdai</term>
<term>Baseline</term>
<term>Bath ankylosing spondylitis disease activity index</term>
<term>Bone density</term>
<term>Bone markers</term>
<term>Bone mineral density</term>
<term>Bone turnover</term>
<term>Bronchoalveolar lavage</term>
<term>Cardiovascular disease</term>
<term>Cell viability</term>
<term>Centre</term>
<term>Cervical spine disease</term>
<term>Chest expansion</term>
<term>Chest hrct</term>
<term>Chest radiographs</term>
<term>Clin</term>
<term>Clinical manifestations</term>
<term>Consecutive patients</term>
<term>Control group</term>
<term>Corticosteroid treatment</term>
<term>Daytime sleepiness</term>
<term>Depression scale</term>
<term>Diagnostic criteria</term>
<term>Disease activity</term>
<term>Dmard treatment</term>
<term>Dudley group</term>
<term>Encoding</term>
<term>Encoding mrna</term>
<term>Encoding transcripts</term>
<term>Eosinophilic fasciitis</term>
<term>Epworth sleepiness scale</term>
<term>Erythrocyte sedimentation rate</term>
<term>Fatigue component</term>
<term>Femoral neck</term>
<term>Fetal loss</term>
<term>Fibroblast</term>
<term>Fracture</term>
<term>Further studies</term>
<term>Giant cell arteritis</term>
<term>Healthy control subjects</term>
<term>Healthy controls</term>
<term>Helier hospital</term>
<term>Hospital anxiety</term>
<term>Hrct</term>
<term>Immunosorbent assay</term>
<term>Interstitial</term>
<term>Interstitial abnormalities</term>
<term>Interstitial lung disease</term>
<term>June</term>
<term>Kinase</term>
<term>Letters authors</term>
<term>Ligand</term>
<term>Longitudinal phase</term>
<term>Longitudinal study</term>
<term>Lumbar spine</term>
<term>Lupus</term>
<term>Lupus anticoagulant</term>
<term>Lymphocyte</term>
<term>Methotrexate</term>
<term>Mild right</term>
<term>Military hospital mohamed</term>
<term>Neck circumference</term>
<term>Negative control</term>
<term>Night oximetry</term>
<term>Okadaic acid</term>
<term>Orthopaedic surgery</term>
<term>Other factors</term>
<term>Other hand</term>
<term>Overall basdai scores</term>
<term>Phorbol ester</term>
<term>Plain radiography</term>
<term>Polynuclear neutrophils</term>
<term>Positive control</term>
<term>Product sizes</term>
<term>Protein kinase</term>
<term>Protein kinase inhibitor staurosporine</term>
<term>Psoriatic arthritis</term>
<term>Pulmonary function testing</term>
<term>Reactive protein</term>
<term>Respiratory symptoms</term>
<term>Rheum</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatol</term>
<term>Rheumatology</term>
<term>Risk factors</term>
<term>Second passage</term>
<term>Serum levels</term>
<term>Serum samples</term>
<term>Skeletal sites</term>
<term>Sleepiness</term>
<term>Spinal involvement</term>
<term>Spondylitis</term>
<term>Staurosporine</term>
<term>Stress fracture</term>
<term>Syndrome</term>
<term>Synovial</term>
<term>Synovial fibroblasts</term>
<term>Systemic</term>
<term>Systemic disease</term>
<term>Systemic lupus erythematosus</term>
<term>Temporal arteritis</term>
<term>Turbidimetric immunoassay</term>
<term>Turnover</term>
<term>Untreated cells</term>
<term>Variable effects</term>
<term>York criteria</term>
<term>Young patients</term>
<term>anti-annexin antibodies</term>
<term>cerebrovascular disease</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Aanxv</term>
<term>Abnormality</term>
<term>Aicher</term>
<term>American college</term>
<term>Ankylosing</term>
<term>Ankylosing spondylitis</term>
<term>Antinuclear antibodies</term>
<term>Antiphospholipid antibodies</term>
<term>Antiphospholipid syndrome</term>
<term>Apnoea syndrome</term>
<term>Arteritis</term>
<term>Arthritis</term>
<term>Arthritis rheum</term>
<term>Basdai</term>
<term>Baseline</term>
<term>Bath ankylosing spondylitis disease activity index</term>
<term>Bone density</term>
<term>Bone markers</term>
<term>Bone mineral density</term>
<term>Bone turnover</term>
<term>Bronchoalveolar lavage</term>
<term>Cardiovascular disease</term>
<term>Cell viability</term>
<term>Centre</term>
<term>Cervical spine disease</term>
<term>Chest expansion</term>
<term>Chest hrct</term>
<term>Chest radiographs</term>
<term>Clin</term>
<term>Clinical manifestations</term>
<term>Consecutive patients</term>
<term>Control group</term>
<term>Corticosteroid treatment</term>
<term>Daytime sleepiness</term>
<term>Depression scale</term>
<term>Diagnostic criteria</term>
<term>Disease activity</term>
<term>Dmard treatment</term>
<term>Dudley group</term>
<term>Encoding</term>
<term>Encoding mrna</term>
<term>Encoding transcripts</term>
<term>Eosinophilic fasciitis</term>
<term>Epworth sleepiness scale</term>
<term>Erythrocyte sedimentation rate</term>
<term>Fatigue component</term>
<term>Femoral neck</term>
<term>Fetal loss</term>
<term>Fibroblast</term>
<term>Fracture</term>
<term>Further studies</term>
<term>Giant cell arteritis</term>
<term>Healthy control subjects</term>
<term>Healthy controls</term>
<term>Helier hospital</term>
<term>Hospital anxiety</term>
<term>Hrct</term>
<term>Immunosorbent assay</term>
<term>Interstitial</term>
<term>Interstitial abnormalities</term>
<term>Interstitial lung disease</term>
<term>June</term>
<term>Kinase</term>
<term>Letters authors</term>
<term>Ligand</term>
<term>Longitudinal phase</term>
<term>Longitudinal study</term>
<term>Lumbar spine</term>
<term>Lupus</term>
<term>Lupus anticoagulant</term>
<term>Lymphocyte</term>
<term>Methotrexate</term>
<term>Mild right</term>
<term>Military hospital mohamed</term>
<term>Neck circumference</term>
<term>Negative control</term>
<term>Night oximetry</term>
<term>Okadaic acid</term>
<term>Orthopaedic surgery</term>
<term>Other factors</term>
<term>Other hand</term>
<term>Overall basdai scores</term>
<term>Phorbol ester</term>
<term>Plain radiography</term>
<term>Polynuclear neutrophils</term>
<term>Positive control</term>
<term>Product sizes</term>
<term>Protein kinase</term>
<term>Protein kinase inhibitor staurosporine</term>
<term>Psoriatic arthritis</term>
<term>Pulmonary function testing</term>
<term>Reactive protein</term>
<term>Respiratory symptoms</term>
<term>Rheum</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatol</term>
<term>Rheumatology</term>
<term>Risk factors</term>
<term>Second passage</term>
<term>Serum levels</term>
<term>Serum samples</term>
<term>Skeletal sites</term>
<term>Sleepiness</term>
<term>Spinal involvement</term>
<term>Spondylitis</term>
<term>Staurosporine</term>
<term>Stress fracture</term>
<term>Syndrome</term>
<term>Synovial</term>
<term>Synovial fibroblasts</term>
<term>Systemic</term>
<term>Systemic disease</term>
<term>Systemic lupus erythematosus</term>
<term>Temporal arteritis</term>
<term>Turbidimetric immunoassay</term>
<term>Turnover</term>
<term>Untreated cells</term>
<term>Variable effects</term>
<term>York criteria</term>
<term>Young patients</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Maladie cardio-vasculaire</term>
<term>Chiffre d'affaires</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list>
<country>
<li>Slovénie</li>
</country>
</list>
<tree>
<country name="Slovénie">
<noRegion>
<name sortKey="Gaspersi, N" sort="Gaspersi, N" uniqKey="Gaspersi N" first="N" last="Gašperši">N. Gašperši</name>
</noRegion>
<name sortKey=" U Nik, S" sort=" U Nik, S" uniqKey=" U Nik S" first="S" last=" U Nik">S. U Nik</name>
<name sortKey="Bozi, B" sort="Bozi, B" uniqKey="Bozi B" first="B" last="Boži">B. Boži</name>
<name sortKey="Kveder, T" sort="Kveder, T" uniqKey="Kveder T" first="T" last="Kveder">T. Kveder</name>
<name sortKey="Rot, U" sort="Rot, U" uniqKey="Rot U" first="U" last="Rot">U. Rot</name>
<name sortKey="Rozman, B" sort="Rozman, B" uniqKey="Rozman B" first="B" last="Rozman">B. Rozman</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008064 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008064 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:E0B51C21E16FC9007046B8B0F3E4A2CA9904BE1A
   |texte=   Anti-annexin V antibodies in patients with cerebrovascular disease
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022